In short
Three things go wrong for women in standard executive checks.
- Cardiovascular risk is underestimated. Among 6739 middle aged women rated low or borderline risk, 36 per cent had coronary calcium, and its presence doubled their risk of events.
- Iron deficiency is missed. Premenopausal women, especially with heavy periods, should be screened, and annually if periods are heavy.
- Perimenopause is mistaken for stress. The two produce the same symptoms and are treated completely differently.
Treatment Overview
Why is cardiovascular risk underestimated in women?
Because risk calculators give women lower scores, and because women have less coronary calcium at any given age and risk level than men do, while the prognostic value of that calcium is the same.
The evidence is striking. In a meta analysis of five population studies covering 6739 middle aged women at low or borderline 10 year risk, 36 per cent had detectable coronary calcium. Its presence doubled the risk of cardiovascular events over 7 to 12 years and reclassified 20 per cent of them into a more accurate risk category.
So a low calculated risk in a woman under 60 is worth a second look where there is a family history or another risk enhancer.
What is specific about iron?
| Who is screened | Premenopausal women, particularly with previous pregnancies or heavy periods |
| How often | Annually is reasonable at highest risk, such as heavy menstrual bleeding |
| Why it matters | It produces fatigue, poor concentration and exercise intolerance long before anaemia appears |
This is not a routine test for every adult, but it is one for a specific group that standard executive panels often treat identically to men.
Perimenopause or stress?
They produce the same list: fatigue, broken sleep, irritability, low mood, poor concentration. The difference is the cycle history, and it has to be asked about.
Mood disorders are genuinely more common during the transition. The risk of new onset depression in these years is around 30 per cent, and around 60 per cent for women with a previous history.
Sleep is another trap. In women investigated for sleep disturbance around menopause, 53 per cent had sleep apnoea, restless legs, or both. Those need their own treatment and do not respond to hormones.
What screening is women specific?
- Breast: discussed from 40, every one to two years by preference, with the false positive and overdiagnosis risk stated before you decide
- Cervical: from 21 to 25, by HPV testing, cytology or both, with the interval depending on the method
- Ovarian: not screened at average risk. A concerning family history means genetic assessment, not routine testing
- Family history on both sides, which is what identifies hereditary breast and ovarian cancer syndromes and matters more than any single test
What about clinical breast examination?
Not recommended as screening, and neither is breast self examination, except for women who specifically want to do it and have been taught to distinguish normal tissue from a suspicious lump.
Who Is a Good Candidate?
- You are 40 or over and want screening organised properly rather than piecemeal
- Fatigue, poor concentration and broken sleep have become normal and you are not sure why
- Your cycle has changed and you are not sure whether that explains how you feel
- Periods are heavy, or you have had several pregnancies
- There is breast, ovarian or colorectal cancer in your family, on either side
- A new breast lump or nipple change, which needs assessment now rather than at the next screening round
- Bleeding between periods, after sex, or after the menopause
- Chest discomfort or breathlessness on exertion, which is as important in women as in men and is more often dismissed
What Happens During the Consultation
-
1
Cycle history and symptom pattern
When your cycle changed and how, alongside sleep, mood, energy and concentration. This is what separates perimenopause from workload, and it cannot be answered by a hormone level in the transition.
-
2
The panel, including iron
Lipids, glucose or HbA1c, kidney and liver function, and ferritin where you are premenopausal with heavy periods or previous pregnancies. Thyroid where you have a risk factor for it.
-
3
Cardiovascular risk, read carefully
Calculated with a validated model, then read alongside your risk enhancers. Where there is family history and the number looks reassuringly low, a calcium score is discussed, because it reclassifies a fifth of women in that position.
-
4
Screening and the plan
Breast and cervical screening arranged with the benefits and harms stated, family history on both sides reviewed, and a review interval set.
Program Structure & Follow-Up
Intervals
| Breast | Discussed from 40, every one to two years by preference, while life expectancy is at least 10 years |
| Cervical | From 21 to 25, interval by method, usually stopping at 65 with adequate prior normal results |
| Iron | Annually at highest risk, otherwise as indicated |
| Cardiovascular risk | Every three to five years from 20, yearly at borderline risk or above |
| Colorectal | From 45 |
If the picture points to perimenopause
Treatment is discussed on its own terms, including that contraception is still needed until 12 months without a period, and that oestrogen improves mood during the transition but not after menopause.
If iron is low
The cause is looked for rather than just replacing it. Heavy periods are the usual explanation in premenopausal women, but blood loss and malabsorption both need excluding.
If a calcium score is raised
The targets tighten in exactly the same way as for men. A score of 100 to 299 brings an LDL target under 70 mg/dL, and 300 or more a target under 55.
Benefits, Limits & Safety
What this gets right that packages get wrong
- Cardiovascular risk read in the knowledge that calculators understate it in women
- Iron checked in the group that actually needs it
- Perimenopause considered rather than assumed to be stress
- Sleep disorders looked for, not attributed to hormones by default
- Family history taken on both sides, which is what identifies hereditary cancer syndromes
The honest position on mammography
It carries a substantial risk of false positives and of overdiagnosis, and the absolute benefit is smaller under 50 because breast cancer is less common and mammography less sensitive in younger women.
Some women, given that information, choose not to be screened, particularly as breast cancer mortality has fallen with better treatment. That is a legitimate decision and it is respected.
What is not offered
- Ovarian cancer screening at average risk
- Clinical breast examination as screening
- Whole body scans and multi cancer blood tests
- Compounded hormone mixtures or saliva hormone testing
- Broad hormone panels ordered without a question attached
What actually reduces risk
The same things as for men, with the same effect sizes. Activity added 1.5 years of life expectancy at 50 at moderate levels and 3.5 years at high levels for women in the Framingham data.
What is worth finding
Underestimated cardiovascular risk, iron deficiency, an unrecognised perimenopause, a sleep disorder, and a family history that changes the screening plan.
Intervals
Breast every one to two years from 40, cervical from 21 to 25 by method, iron annually at highest risk, cardiovascular risk every three to five years.
Not offered
Ovarian screening at average risk, clinical breast examination, whole body scans, multi cancer blood tests and compounded hormones.
Cost & Program Investment
The consultation and each test are quoted before they are ordered. Ferritin and thyroid are included where you have a specific indication rather than by default, and you are told which applies to you. Breast and cervical screening are arranged rather than simply recommended, and any onward referral, including genetic assessment where the family history warrants it, is discussed and quoted first.
Frequently Asked Questions
Probably, but with a caveat. Calculators give women lower scores, and 36 per cent of middle aged women rated low or borderline risk had detectable coronary calcium, which doubled their event risk. With a family history, that is worth a second look.
Both produce the same symptoms, and the answer comes from your cycle history rather than a hormone level, because levels swing week to week in the transition and can look normal on a good month.
If you are premenopausal, especially with heavy periods or previous pregnancies, yes. Annually is reasonable if periods are heavy. It is not a routine test for every adult, but it is for that group.
That is a decision to make with the information. The absolute benefit is smaller under 50 and the false positive and overdiagnosis risks are real. Every one to two years is the usual interval for those who choose to screen.
Not at average risk. It is not recommended. A concerning family history on either side is a reason for genetic assessment rather than routine screening.
It is not recommended as screening. If you want to, it should be after careful instruction on distinguishing normal tissue from a suspicious lump. Any new lump or nipple change needs assessment regardless.
Not necessarily, and assuming it is causes real problems. In women investigated for sleep disturbance around menopause, 53 per cent had sleep apnoea, restless legs or both, and those need their own treatment.
Evidence
Where this information comes from
Every figure on this page is taken from the sources below. All of them are free to read, so you can check them yourself.
- Cardiovascular diseases
- Cardiovascular disease: risk assessment and reduction
- Hypertension in adults: diagnosis and management
This page is general medical information and does not replace a personal consultation. Trial results are averages across large groups, not a prediction for any one person.